Page last updated: 2024-08-24

xanomeline and Psychoses

xanomeline has been researched along with Psychoses in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, MB; Bymaster, F; Fink-Jensen, A; Gerlach, J; Lundbaek, JA; Peacock, L; Werge, T1
Bymaster, FP; Fink-Jensen, A; Hart, JC; Jeppesen, L; Peters, SC; Rasmussen, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Swedberg, MD1

Other Studies

2 other study(ies) available for xanomeline and Psychoses

ArticleYear
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:6

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Cebus; Male; Muscarinic Agonists; Psychotic Disorders; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, Muscarinic; Thiadiazoles

2003
Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.
    Schizophrenia research, 2000, May-05, Volume: 42, Issue:3

    Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Brain; Cholinergic Agonists; Conditioning, Psychological; Disease Models, Animal; Dopamine; Electrophysiology; Male; Mice; Mice, Inbred Strains; Muscarinic Agonists; Neurons; Psychotic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Schizophrenia; Thiadiazoles

2000